Abstract: The present invention provides compounds, pharmaceutical compositions, methods of inhibiting ROR? activity and/or reducing the amount of IL-17 in a subject, and methods of treating various medical disorders using such compounds and pharmaceutical compositions.

Abstract: The present invention provides methyl- and trifluoromethyl-substituted pyrrolopyridines, pharmaceutical compositions thereof, methods of modulating ROR? activity and/or reducing the amount of IL-17 in a subject, and methods of treating various medical disorders using such pyrrolopyridines and pharmaceutical compositions thereof.

Abstract: The present invention provides compounds, pharmaceutical compositions, methods of inhibiting ROR? activity and/or reducing the amount of IL-17 in a subject, and methods of treating various medical disorders using such compounds and pharmaceutical compositions.

Abstract: The present invention provides sulfonamide-substituted indoles and Methods of Use Thereof-substituted pyrro-lopyridines, pharmaceutical compositions thereof methods of modulating RORy activity and/or reducing the amount of IL-17 in a subject, and methods of treating various medical disorders using such indoles and pharmaceutical compositions thereof.

Abstract: Compounds, pharmaceutically acceptable salts thereof are disclosed wherein the compounds have the structure of Formula (I) as defined in the specification. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed.

Abstract: The present invention provides compounds, pharmaceutical compositions, methods of inhibiting ROR? activity and/or reducing the amount of IL-17 in a subject, and methods of treating various medical disorders using such compounds and pharmaceutical compositions.

Abstract: The present invention provides methoxy-substituted pyrrolopyridines, pharmaceutical compositions thereof, methods of modulating ROR? activity and/or reducing the amount of IL-17 in a subject, and methods of treating various medical disorders using such pyrrolopyridines and pharmaceutical compositions thereof.

Abstract: Embodiments of the present disclosure provide techniques for rendering content from a media item. According to these embodiments, from a file of the media item, track(s) in a group data structure corresponding to the type of content are identified as candidate track(s). From other tracks in the file, a determination may be made whether another track corresponds to the type of content. When another track corresponds to the type of content, feature tags in the file that are associated may be compared with the other track to capabilities of a player device that is to render the type of content. When the feature tags match capabilities of the player device, the other track may be included as a candidate track. Thereafter, a track may be selected from the candidate tracks and rendered by the player device.

Abstract: A mechanical valve assembly for the control of a gas flow to a gas appliance, the mechanical valve assembly comprising: a housing; a gas inlet port associated with the housing; a gas outlet port associated with the housing; a timer-controlled valve operable to open and close a gas flow between the inlet port and outlet port; and a manually-operated emergency shut-off valve positioned between the inlet port and the outlet port, ahead of the timer-controlled valve relative to a direction of the gas flow through the mechanical valve assembly.

Abstract: The present invention provides compounds, pharmaceutical compositions, methods of inhibiting ROR? activity and/or reducing the amount of IL-17 in a subject, and methods of treating various medical disorders using such compounds and pharmaceutical compositions.

Abstract: The present invention provides methyl- and trifluoromethyl-substituted pyrrolopyridines, pharmaceutical compositions thereof, methods of modulating ROR? activity and/or reducing the amount of IL-17 in a subject, and methods of treating various medical disorders using such pyrrolopyridines and pharmaceutical compositions thereof.

Abstract: Methods, data processing systems and machine readable non-transitory storage media are described that can provide, in one embodiment, a non-time based description of types of metadata in a time based metadata track that can be associated with, in time, a time based media track. The description can include a set of keys, or other identifiers, that specify the types of metadata in the metadata track, and the description can also include values describing the structure of each key and values describing how to interpret each key.

Abstract: The present invention provides compounds, pharmaceutical compositions, methods of inhibiting ROR? activity and/or reducing the amount of IL-17 in a subject, and methods of treating various medical disorders using such compounds and pharmaceutical compositions.

Abstract: Methods, data processing systems and machine readable non-transitory storage media are described that can provide, in one embodiment, a non-time based description of types of metadata in a time based metadata track that can be associated with, in time, a time based media track. The description can include a set of keys, or other identifiers, that specify the types of metadata in the metadata track, and the description can also include values describing the structure of each key and values describing how to interpret each key.

Abstract: Methods, data processing systems and machine readable non-transitory storage media are described that can provide, in one embodiment, a non-time based description of types of metadata in a time based metadata track that can be associated with, in time, a time based media track. The description can include a set of keys, or other identifiers, that specify the types of metadata in the metadata track, and the description can also include values describing the structure of each key and values describing how to interpret each key.

Abstract: A description of types of metadata can provide, in one embodiment, an index to the types of metadata in a time based metadata track that can be associated with a time based media track having audio or video or both. The description can be non-time based and be separate from the metadata track, and the description can be examined to determine whether a particular type of metadata exists in the time based metadata track without having to search through the track to determine whether the particular type of metadata exists.

Abstract: A content streaming system, such as an HTTP streaming system, can use a variant audio playlist that identifies different audio playlists, such as one playlist in English and one playlist in Spanish, for the same program such as a video program which is specified by a video playlist which can be separate from the variant audio playlist. A client can use the variant audio playlist to select a particular audio content for the same program, and the particular audio content can be referred to by one URL in the variant audio playlist, among a set of alternative URLs, in the variant audio playlist, for alternative audio content.

Abstract: A content streaming system, such as an HTTP streaming system, can use a variant audio playlist that identifies different audio playlists, such as one playlist in English and one playlist in Spanish, for the same program such as a video program which is specified by a video playlist which can be separate from the variant audio playlist. A client can use the variant audio playlist to select a particular audio content for the same program, and the particular audio content can be referred to by one URL in the variant audio playlist, among a set of alternative URLs, in the variant audio playlist, for alternative audio content.

Abstract: A description of types of metadata can provide, in one embodiment, an index to the types of metadata in a time based metadata track that can be associated with a time based media track having audio or video or both. The description can be non-time based and be separate from the metadata track, and the description can be examined to determine whether a particular type of metadata exists in the time based metadata track without having to search through the track to determine whether the particular type of metadata exists.

Abstract: Methods, data processing systems and machine readable non-transitory storage media are described that can provide, in one embodiment, a non-time based description of types of metadata in a time based metadata track that can be associated with, in time, a time based media track. The description can include a set of keys, or other identifiers, that specify the types of metadata in the metadata track, and the description can also include values describing the structure of each key and values describing how to interpret each key.